I never expect anything other than a sobering 10q

I never expect anything other than a sobering 10q from a pre-rev biotech. By their very definition there’s no $$ coming in, so these companies almost always look sobering on paper.

I’m just relieved they filed the goddamn thing.

Nothing else matters except a partner(s) and getting the bullshit holds lifted.